Sofinnova Partners

Venture Capital London, France Est. 1972
Visit website ↗ LinkedIn
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—

About

Sofinnova Partners is a European venture capital firm focused on life sciences, with core specializations in healthcare and sustainability. Headquartered in Paris, with additional offices in London and Milan, the firm combines scientific, medical, and business expertise to support companies across the full lifecycle of venture investment. Its approach includes hands-on company building, from seed-stage formation to later-stage growth, working closely with entrepreneurs as a lead or cornerstone investor to advance technologies with broad societal impact.

Established in 1972, Sofinnova Partners is one of Europe’s longest-standing life sciences investors. Over five decades, it has backed more than 500 companies and contributed to the development of multiple global market leaders. The firm currently manages over €4 billion across its investment strategies.

Portfolio

No portfolio companies in this dataset yet.

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Sofinnova Partners' primary investment focus?
Sofinnova Partners is a European venture capital firm primarily focused on life sciences, with core specializations in healthcare and sustainability.
When was Sofinnova Partners established?
Sofinnova Partners was established in 1972, making it one of Europe’s longest-standing life sciences investors.
How much capital does Sofinnova Partners currently manage?
Sofinnova Partners currently manages over €4 billion across its investment strategies.
Can you name some notable companies in Sofinnova Partners' portfolio?
Notable companies in Sofinnova Partners' portfolio include Endoron Medical and Pi-Cardia. For a full portfolio, please refer to startupim.
What is Sofinnova Partners' approach to company building?
Sofinnova Partners employs a hands-on company building approach, from seed-stage formation to later-stage growth, often acting as a lead or cornerstone investor.
What was a significant recent fund closing for Sofinnova Partners?
According to startupim data, Sofinnova Partners closed Capital XI in November 2025, raising €650M ($750M) to back early-stage healthcare deals, significantly exceeding its initial target.
What is Sofinnova Partners' geographic presence?
Sofinnova Partners is headquartered in Paris, France, with additional offices in London, UK, and Milan, Italy.
What is the typical investment range for Sofinnova Partners?
Sofinnova Partners' investment range is typically between $5M and $27M.
How many companies has Sofinnova Partners backed over its history?
Over five decades, Sofinnova Partners has backed more than 500 companies.